APA (7th ed.) Citation

Y, G., L, L., F, Z., Y, C., M, J., & FS, X. Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Gao, Li L, Zhao F, Cheng Y, Jin M, and Xue FS. Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Dove Medical Press.

MLA (9th ed.) Citation

Y, Gao, et al. Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy. Dove Medical Press.